报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | -6.3% | -12.1% | 5.41% | 123/129 | 4.79% | 迈瑞医疗 | 28.68% | 行业排名> |
2024-06-30 | -6.66% | -3.58% | -722.22% | 123/129 | 3.05% | 迈瑞医疗 | 20.2% | 行业排名> |
2024-03-31 | -0.81% | -209.46% | 95.21% | 113/129 | 1.68% | 迈瑞医疗 | 9.12% | 行业排名> |
2023-12-31 | -16.91% | -30.08% | -200.89% | 120/129 | 5.06% | 迈瑞医疗 | 33.21% | 行业排名> |
2023-09-30 | -5.62% | 34.04% | 12.6% | 118/129 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
2023-06-30 | -6.43% | -8.25% | -968.92% | 120/129 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
2023-03-31 | 0.74% | 125.52% | 105.69% | 93/129 | 2.29% | 安杰思 | 8.56% | 行业排名> |
2022-12-31 | -13% | -26.09% | -52.58% | 120/129 | 13.44% | 九安医疗 | 146.56% | 行业排名> |
2022-09-30 | -8.52% | -29.68% | -43.43% | 114/129 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
2022-06-30 | -5.94% | -21.72% | -104.83% | 120/129 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
2022-03-31 | -2.9% | -16.94% | 71.87% | 107/129 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
2021-12-31 | -10.31% | 0.77% | -56.93% | 122/129 | 17.49% | 热景生物 | 121.78% | 行业排名> |
2021-09-30 | -6.57% | -1.23% | -34.63% | 103/129 | 15.94% | 热景生物 | 99.69% | 行业排名> |
2021-06-30 | -4.88% | 46.55% | -96.77% | 115/129 | 11.54% | 热景生物 | 99.09% | 行业排名> |
2021-03-31 | -2.48% | 27.27% | 76.13% | 92/129 | 6.23% | 热景生物 | 57.63% | 行业排名> |
2020-12-31 | -10.39% | -77% | -60.09% | 121/129 | 25.82% | 中红医疗 | 168% | 行业排名> |
2020-09-30 | -6.49% | 2% | 28.92% | 86/129 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
2020-06-30 | -9.13% | 0.98% | -167.74% | 109/129 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
2020-03-31 | -3.41% | 2% | 41.91% | 75/129 | 3.4% | 圣湘生物 | 29.33% | 行业排名> |
2019-12-31 | -5.87% | 51.45% | 36.33% | 112/129 | 14.38% | 健尔康 | 84.09% | 行业排名> |
2019-06-30 | -9.22% | 61.24% | 23.74% | 74/129 | 6.73% | 祥生医疗 | 28.56% | 行业排名> |
2018-12-31 | -12.09% | -10.61% | 49.18% | 105/129 | 12.98% | 心脉医疗 | 31.04% | 行业排名> |
2018-06-30 | -23.79% | -1662.22% | -117.66% | 59/129 | 3.21% | 新华医疗 | 13.55% | 行业排名> |
2017-12-31 | -10.93% | 56.49% | -709.63% | 99/129 | 13.82% | 安旭生物 | 48.71% | 行业排名> |
2017-06-30 | -1.35% | 85.53% | 94.63% | 54/129 | 5.9% | 迈瑞医疗 | 38.33% | 行业排名> |
2016-12-31 | -25.12% | -30.83% | -169.24% | 78/129 | 16.21% | 明德生物 | 14.54% | 行业排名> |
2016-06-30 | -9.33% | 2% | 51.41% | 50/129 | 6.26% | 迈瑞医疗 | 11% | 行业排名> |
2015-12-31 | -19.2% | 78.02% | 78.02% | 60/129 | 15.95% | 安旭生物 | 59.22% | 行业排名> |